---
title: "SBC Medical | 8-K: FY2026 Q1 Revenue Beats Estimate at USD 43.06 M"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286402275.md"
datetime: "2026-05-14T10:52:21.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286402275.md)
  - [en](https://longbridge.com/en/news/286402275.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286402275.md)
---

# SBC Medical | 8-K: FY2026 Q1 Revenue Beats Estimate at USD 43.06 M

Revenue: As of FY2026 Q1, the actual value is USD 43.06 M, beating the estimate of USD 41.66 M.

EPS: As of FY2026 Q1, the actual value is USD 0.11, beating the estimate of USD 0.1.

EBIT: As of FY2026 Q1, the actual value is USD 17.71 M.

#### Financial Highlights for the Three Months Ended March 31, 2026

-   **Total Revenues, net**: Total revenues, net, were $43,060,562, representing a 9% year-over-year decrease .
-   **Net Income Attributable to SBC Medical Group Holdings Incorporated**: Net income attributable to SBC Medical Group Holdings Incorporated was $11,308,071, representing a 47% year-over-year decrease .
-   **Net Income Margin**: The net income margin was 26% for the first quarter of 2026, a year-over-year decrease of 19 percentage points .
-   **EBITDA**: EBITDA was $18,390,449, representing a 26% year-over-year decrease .
-   **EBITDA Margin**: The EBITDA margin was 43% for the first quarter of 2026, a year-over-year decrease of 10 percentage points .
-   **Return on Equity**: Return on Equity was 18%, representing a year-over-year decrease of 23 percentage points .

#### Operational Metrics for the Three Months Ended March 31, 2026

-   **Number of Franchise Locations**: The number of franchise locations was 284 as of March 31, 2026, an increase of 33 locations from March 31, 2025 .
-   **Number of Customers**: The company served 6.76 million customers in the last twelve months ended March 31, 2026, a 10% year-over-year increase .
-   **Repeat Rate for Customers**: The repeat rate for customers who visited franchisee’s clinics twice or more was 72% .

#### Income Statement Highlights for the Three Months Ended March 31, 2026

-   **Gross Profit**: Gross profit was $30,346,734, compared to $37,733,084 for the three months ended March 31, 2025 .
-   **Operating Expenses**: Operating expenses were $12,626,719, compared to $13,531,010 for the three months ended March 31, 2025 .
-   **Income from Operations**: Income from operations was $17,720,015, compared to $24,202,074 for the three months ended March 31, 2025 .
-   **Income Tax Expense**: Income tax expense was $7,527,591, compared to $9,959,457 for the three months ended March 31, 2025 .
-   **Net Income**: Net income was $11,329,020, compared to $21,491,950 for the three months ended March 31, 2025 .

#### Cash Flow Highlights for the Three Months Ended March 31, 2026

-   **Net Cash Provided by Operating Activities**: Net cash provided by operating activities was $9,231,938, compared to $1,928,621 for the three months ended March 31, 2025 .
-   **Net Cash Used in Investing Activities**: Net cash used in investing activities was - $528,025, compared to - $978,807 for the three months ended March 31, 2025 .
-   **Net Cash Used in Financing Activities**: Net cash used in financing activities was - $1,842,414, compared to - $280,380 for the three months ended March 31, 2025 .
-   **Cash and Cash Equivalents**: Cash and cash equivalents were $167,305,095 as of March 31, 2026, compared to $132,055,823 as of March 31, 2025 .

#### Balance Sheet Highlights as of March 31, 2026

-   **Total Assets**: Total assets were $388,019,576, up from $380,447,946 as of December 31, 2025 .
-   **Total Liabilities**: Total liabilities were $117,635,399, up from $117,143,240 as of December 31, 2025 .
-   **Total Stockholders’ Equity**: Total stockholders’ equity was $270,384,177, up from $263,304,706 as of December 31, 2025 .

#### Outlook

SBC Medical Group Holdings Incorporated plans to continue its multi-brand strategy in aesthetic dermatology, expand its non-aesthetic medical business, and strengthen its operational foundation in overseas markets . The company will also pursue opportunities in the longevity market and enhance services through AI utilization, aiming to build a sustainable and continuously growing healthcare platform .

### Related Stocks

- [SBC.US](https://longbridge.com/en/quote/SBC.US.md)

## Related News & Research

- [SBC Medical Group Faces Nasdaq Compliance Governance Challenges](https://longbridge.com/en/news/292728234.md)
- [SBC Medical Group Shareholders Approve Board, Charter Changes at Annual Meeting](https://longbridge.com/en/news/292368834.md)
- [RCS - marvnBoost - marvnBoost Heads to SBC Summit Lisbon](https://longbridge.com/en/news/293923187.md)
- [Baxter Q2 2026 Earnings Preview](https://longbridge.com/en/news/294224876.md)
- [SBC Medical Group stockholders adopt amended charter opting out of DGCL Section 203](https://longbridge.com/en/news/292675613.md)